AppShopper

CHF Trials

       iOS Universal

Wading through the alphabet soup of clinical trials in heart failure is a challenge for anyone. From the VA Cooperative Study to STICH, ACE-inhibitors to exercise therapy, CHF Trials covers it all. Whether you are an intern or a cardiologist, this app is an excellent tool for learning about and staying abreast of new and important studies.

Developed by physicians trained at The Johns Hopkins Hospital and the University of California at San Francisco, CHF Trials gives you reliable, rapid, and easy access to trial information with expert opinion that places each study in context. More than just an abstract, each entry contains all of the important information in an easy to read and understand format.

Sort trials by:

•Study Subject
•Inclusion LVEF and NYHA Class
•Acute Heart Failure Trials
•Device Therapy Trials

Update section alerts you to new trial additions and updates to existing trial commentary.

Each entry contains:

•Trial purpose
•Important points
•Link to PubMed
•Inclusion and exclusion criteria
•Methods and procedures
•Baseline characteristics
•Baseline therapy
•Primary and secondary outcomes
•Applicable ACC/AHA and ESC guidelines
•Detailed references to guide further reading

Current subjects include:

•ACEI/ARBs
•Beta-Blockers
•Aldosterone Receptor Blockers
•Vasodilators
•Inotropes/Inodilators
•Diuretics
•Vasopressin Receptor Blockers
•Sinus Node Inhibitors
•Calcium Channel Blockers
•Antiarrhythmics
•Atrial Fibrillation
•Statins
•Fish Oil (n-3 PUFA)
•Iron Therapy
•ICDs/CRT
•LVADs
•Surgical Therapy
•Pulmonary Artery Catheters
•Telemonitoring
•Ultrafiltration
•Non-Invasive Ventilation
•BNP-Guided Therapy
•Exercise-Therapy
•Counseling

What's new

• In this update, I have revised the commentary on some of the major CRT trials, including MADIT-CRT, RAFT, Rethinq, and CARE-HF to reflect evolving opinion and evidence.

• Updated commentary on CHAMPION (pulmonary artery sensor) reflecting recent FDA advisory statements.

• Updated commentary on ANDROMEDA (dronedarone) reflecting publication of PALLAS and recent FDA statements.

• Updated commentary on SHIFT (ivabradine) reflecting new publications and opinion.

• Updated commentary on VMAC (nesiritide vs. nitroglycerin and placebo), including discussion of nitroglycerin, and the results of ASCEND-HF (nesiritide vs. standard care in acute heart failure).

• If you like CHF Trials, please take the time to rate it on the App store!

David Majure, MD MPH

Screenshots

	Screenshot 1 of 9

Share with Others

Last changed:

Jan 06, 2012

Category:

Medical

Developer:

Clinical AppStracts LLC

Version:

3.3

Average Rating:

5.00 (25)

Size:

1.2 MB

Other Apps By This Developer